πŸ‡ΊπŸ‡Έ FDA
Patent

US 7148376

Polymorphic forms of nateglinide

granted A61KA61K31/16A61K31/198

Quick answer

US patent 7148376 (Polymorphic forms of nateglinide) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
51
CPC classes
A61K, A61K31/16, A61K31/198